Manuel Litchman MD
CIK 1709485 · View on SEC EDGAR ↗
First SEC filing: June 30, 2017 · Latest: June 30, 2017
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Sept. 13, 2022 | MBIO | P | 5,000 | $0.52 | $2,600 | 1,098,987 Direct | +0.46% | Acquired | -99.9% (price as of 2026-08-20) |
| March 18, 2022 | MBIO | P | 5,000 | $0.74 | $3,700 | 1,032,987 Direct | +0.49% | Acquired | -99.9% (price as of 2026-08-20) |
| Oct. 27, 2021 | MBIO | P | 65,000 | $2.24 | $145,600 | 1,027,987 Direct | +6.75% | Acquired | -100.0% (price as of 2026-08-20) |
| July 30, 2021 | MBIO | P | 86,206 | $2.91 | $250,859 | 960,241 Direct | +9.86% | Acquired | -100.0% (price as of 2026-08-20) |
| March 5, 2021 | MBIO | P | 165,562 | $3.12 | $516,553 | 825,408 Direct | +25.09% | Acquired | -100.0% (price as of 2026-08-20) |
| Dec. 15, 2020 | MBIO | P | 100,000 | $2.91 | $291,000 | 654,846 Direct | +18.02% | Acquired | -100.0% (price as of 2026-08-20) |
| June 11, 2020 | MBIO | P | 153,846 | $3.25 | $500,000 | 488,846 Direct | +45.92% | Acquired | -100.0% (price as of 2026-08-20) |
| May 22, 2020 | MBIO | S | 8,348 | $3.04 | $25,378 | 813,035 Direct | -1.02% | Disposed | -100.0% (price as of 2026-08-20) |
| May 22, 2020 | MBIO | S | 4,025 | $3.04 | $12,236 | 821,383 Direct | -0.49% | Disposed | -100.0% (price as of 2026-08-20) |
| May 21, 2020 | MBIO | P | 90,000 | $3.13 | $281,700 | 335,000 Direct | +36.73% | Acquired | -100.0% (price as of 2026-08-20) |
| May 14, 2020 | MBIO | P | 90,000 | $2.79 | $251,100 | 245,000 Direct | +58.06% | Acquired | -100.0% (price as of 2026-08-20) |
| Dec. 10, 2018 | MBIO | P | 8,000 | $3.35 | $26,800 | 28,000 Direct | +40.00% | Acquired | -100.0% (price as of 2026-08-20) |
| Dec. 4, 2018 | MBIO | P | 7,500 | $3.60 | $27,000 | 20,000 Direct | +60.00% | Acquired | -100.0% (price as of 2026-08-20) |
| Nov. 26, 2018 | MBIO | P | 5,000 | $3.87 | $19,350 | 12,500 Direct | +66.67% | Acquired | -100.0% (price as of 2026-08-20) |
| Nov. 21, 2018 | MBIO | P | 5,000 | $4.21 | $21,050 | 7,500 Direct | +200.00% | Acquired | -100.0% (price as of 2026-08-20) |
| Nov. 20, 2018 | MBIO | P | 2,500 | $3.89 | $9,725 | 2,500 Direct | — | Acquired | -100.0% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Initial ownership (Form 3) 2 holdings
Securities held when first becoming an insider, per SEC Form 3.
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
MBIO
President & CEO| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2020 | $430,000 | $250,000 | $560,285 | — | — | — | $827 | $1,241,112 |
| 2019 | $415,222 | $100,782 | — | — | — | — | $820 | $516,824 |
| 2018 | $403,128 | $201,564 | — | — | — | — | $820 | $605,512 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.